In CRC, it was found that IGFBP2 can increase the stability of GPX4 mRNA to promote its expression, and then activate cyclic GMP-AMP synthase (cGAS-STING) signaling pathway to inhibit lipid peroxidation124. Here, GPX4 is linked to colorectal carcinoma.